Table 5 Predicted prostate cancer detection tests performed in Victoria based on linear regression of tests performed in 2015–2019 compared to tests performed in 2020
From: The effect of COVID-19 on prostate cancer testing in Australia
Predicted tests in 2020 (95% prediction interval) | R2 of model | Tests performed in 2020 | Difference (% of predicted) | Significance | |
|---|---|---|---|---|---|
PSA tests | 183,946 (171,194–196,699) | 0.37 | 167,426 | − 16,520 (91) | P = 0.015 (t = 4.12) |
Prostate biopsies | 5522 (4338–6706) | 0.60 | 5201 | − 321 (94) | P = 0.437 (t = 0.86) |